Sloning BioTechnology GmbH Successfully Generated a Unique Type of Gene Mutant Library for Novozymes A/S

PUCHHEIM, Germany--(BUSINESS WIRE)--Sloning BioTechnology GmbH, the provider of enabling technologies for protein engineering applications, has successfully synthesised a unique gene mutant library (SlonoMax™ - Screen) for Novozymes A/S.